These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36990390)

  • 1. Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG).
    Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    Radiother Oncol; 2023 Jun; 183():109640. PubMed ID: 36990390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
    Okano N; Suefuji H; Nakajima M; Tokumaru S; Kubo N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    J Radiat Res; 2023 Jun; 64(Supplement_1):i2-i7. PubMed ID: 37036751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC: A Japanese National Registry Study (J-CROS-LUNG).
    Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shimizu K; Shioyama Y
    J Thorac Oncol; 2024 Mar; 19(3):491-499. PubMed ID: 37924974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon-ion radiotherapy for patients with advanced stage non-small-cell lung cancer at multicenters.
    Karube M; Yamamoto N; Shioyama Y; Saito J; Matsunobu A; Okimoto T; Ohno T; Tsuji H; Nakano T; Kamada T
    J Radiat Res; 2017 Sep; 58(5):761-764. PubMed ID: 28992088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.
    Nakajima M; Yamamoto N; Hayashi K; Karube M; Ebner DK; Takahashi W; Anzai M; Tsushima K; Tada Y; Tatsumi K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
    Radiat Oncol; 2017 Sep; 12(1):144. PubMed ID: 28865463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
    Takahashi W; Nakajima M; Yamamoto N; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Kamada T; Fujisawa T
    Cancer; 2015 Apr; 121(8):1321-7. PubMed ID: 25641119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy.
    Karube M; Yamamoto N; Tsuji H; Kanematsu N; Nakajima M; Yamashita H; Nakagawa K; Kamada T
    Radiother Oncol; 2017 Oct; 125(1):31-35. PubMed ID: 28784437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Carbon-ion Radiotherapy Alone for Stage III Non-small Cell Lung Cancer.
    Anzai M; Yamamoto N; Hayashi K; Nakajima M; Nomoto A; Ogawa K; Tsuji H
    Anticancer Res; 2020 Jan; 40(1):379-386. PubMed ID: 31892590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.
    Jeong J; Taasti VT; Jackson A; Deasy JO
    Radiother Oncol; 2020 Dec; 153():265-271. PubMed ID: 32976878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.
    Shirai K; Kawashima M; Saitoh JI; Abe T; Fukata K; Shigeta Y; Irie D; Shiba S; Okano N; Ohno T; Nakano T
    PLoS One; 2017; 12(4):e0175589. PubMed ID: 28399182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon-ion radiotherapy for octogenarians with locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Ishikawa H; Ogawa K; Tsuji H
    Jpn J Radiol; 2021 Jul; 39(7):703-709. PubMed ID: 33608792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.
    Yamamoto N; Miyamoto T; Nakajima M; Karube M; Hayashi K; Tsuji H; Tsujii H; Kamada T; Fujisawa T
    J Thorac Oncol; 2017 Apr; 12(4):673-680. PubMed ID: 28007628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older With Stage I Non-Small Cell Lung Cancer.
    Karube M; Yamamoto N; Nakajima M; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):542-548. PubMed ID: 26797538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer.
    Okazaki S; Shibuya K; Takura T; Miyasaka Y; Kawamura H; Ohno T
    Cancer Sci; 2022 Feb; 113(2):674-683. PubMed ID: 34820994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of carbon-ion radiotherapy for locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Tsuji H; Ogawa K; Kamada T
    Cancer Sci; 2019 Feb; 110(2):734-741. PubMed ID: 30467928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.
    Osti MF; Agolli L; Valeriani M; Falco T; Bracci S; De Sanctis V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e157-63. PubMed ID: 23182393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
    Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B;
    Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer.
    Xu K; Liang J; Zhang T; Zhou Z; Chen D; Feng Q; Xiao Z; Hui Z; Lu J; Wang X; Deng L; Liu W; Wang J; Zhai Y; Wang J; Bi N; Wang L
    Thorac Cancer; 2021 Mar; 12(6):814-823. PubMed ID: 33501781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I Study of Hypofractionated Carbon-ion Radiotherapy for Stage III Non-small Cell Lung Cancer.
    Saitoh JI; Shirai K; Abe T; Kubo N; Ebara T; Ohno T; Minato K; Saito R; Yamada M; Nakano T;
    Anticancer Res; 2018 Feb; 38(2):885-891. PubMed ID: 29374716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.